All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-35614572

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	35614572	A222V	S	S	COVID-19	R	View
2	35614572	D614G	S	S	COVID-19	R	View
3	35614572	F486I	S	S	COVID-19	R	View
4	35614572	Q57H	ORF3a	ORF3a	COVID-19	R	View
5	35614572	V30L	ORF10	ORF10	COVID-19	R	View
6	35614572	D178Y	NSP3	ORF1a	COVID-19	R	View
7	35614572	A192V	NSP2	ORF1a	COVID-19	R	View
8	35614572	R218C	NSP2	ORF1a	COVID-19	R	View
9	35614572	T85I	NSP2	ORF1a	COVID-19	R	View
10	35614572	R292C	NSP13	ORF1b	COVID-19	R	View
11	35614572	P323L	NSP12	ORF1b	COVID-19	R	View
12	35614572	T739I	NSP12	ORF1b	COVID-19	R	View
13	35614572	A220V	N	N	COVID-19	R	View
14	35614572	G204L	N	N	COVID-19	R	View
15	35614572	G204R	N	N	COVID-19	R	View
16	35614572	P67S	N	N	COVID-19	R	View
17	35614572	R203K	N	N	COVID-19	R	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.